The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Kirsty



Biosimilar Collaborations Ireland LimitedEU/1/20/1506/001-007

Main Information

Trade NameKirsty
Active SubstancesInsulin aspart (iasp)
Dosage FormSolution for injection
Licence HolderBiosimilar Collaborations Ireland Limited
Licence NumberEU/1/20/1506/001-007

Group Information

ATC CodeA10AB05 insulin aspart

Status

License statusAuthorised
Licence Issued05/02/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back